ALUMINIUM PHOSPHIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aluminium phosphide

redox limited - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent

ALUMINIUM PHOSPHIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aluminium phosphide

imtrade australia pty ltd - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent

ALUMINIUM PHOSPHIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aluminium phosphide

parsram exporters pty ltd - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent

ALUMINIUM PHOSPHIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aluminium phosphide

nufarm australia limited - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent

ALUMINIUM PHOSPHIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aluminium phosphide

sumitomo chemical australia pty. limited - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent

ALUMINIUM PHOSPHIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aluminium phosphide

rentokil initial pty ltd - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent

ALUMINIUM PHOSPHIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aluminium phosphide

upl australia pty ltd - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent

ALUMINIUM PHOSPHIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aluminium phosphide

nufarm australia limited - aluminium phosphide - unknown - aluminium phosphide mineral-aluminium active 0.0 - active constituent

Verpamil SR New Zealand - English - Medsafe (Medicines Safety Authority)

verpamil sr

viatris limited - verapamil hydrochloride 240mg;  ; verapamil hydrochloride 240mg; verapamil hydrochloride 240mg; verapamil hydrochloride 240mg; verapamil hydrochloride 240mg - modified release tablet - 240 mg - active: verapamil hydrochloride 240mg   excipient: carnauba wax diethyl phthalate ethanol hypromellose magnesium stearate methylene chloride microcrystalline cellulose opaspray green k-1f-3108 opaspray white k-1r-7000 povidone purified talc purified water sodium alginate active: verapamil hydrochloride 240mg excipient: carnauba wax diethyl phthalate ethanol hypromellose magnesium stearate microcrystalline cellulose opaspray green k-1f-3108 opaspray white k-1r-7000 povidone purified talc purified water   sodium alginate active: verapamil hydrochloride 240mg excipient: carnauba wax diethyl phthalate ethanol hypromellose magnesium stearate microcrystalline cellulose opaspray green k-1f-3108 opaspray white k-1r-7000 povidone purified talc purified water   sodium alginate active: verapamil hydrochloride 240mg excipient: carnauba wax diethyl phthalate ethanol hypromellose magnesium stearate microcrystalline cellulose opaspray green k-1f-3108 opaspray white k-1r-7000 povidone purified talc purified water   sodium alginate active: verapamil hydrochloride 240mg excipient: magnesium stearate microcrystalline cellulose opadry green 85f510048 povidone purified talc purified water   sodium alginate - · essential hypertension.

COMPETACT 15 MG  850 MG Israel - English - Ministry of Health

competact 15 mg 850 mg

tzamal bio-pharma ltd - metformin hydrochloride; pioglitazone as hydrochloride - film coated tablets - metformin hydrochloride 850 mg; pioglitazone as hydrochloride 15 mg - metformin - metformin - competact is indicated as second line treatment of type 2 diabetes mellitus adult patients,particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.after initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in hba1c). in patients who fail to show an adequate response, pioglitazone should be discontinued. in light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained.